Heron Therapeutics, Inc. (HRTX)
NASDAQ·Healthcare·Biotechnology
$1.22
+2.10%
Mkt Cap $187.95M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $39.87M | $40.59M | +1.81% | -$0.03 | -$0.02 | +33.33% | — | — |
| Q4 2025 Nov 4, 2025 | $39.03M | $38.21M | -2.10% | -$0.01 | -$0.05 | -275.09% | — | — |
| Q3 2025 Aug 8, 2025 | $39.06M | $37.20M | -4.75% | -$0.01 | -$0.02 | -100.00% | — | — |
| Q2 2025 May 6, 2025 | $38.25M | $38.90M | +1.71% | -$0.01 | $0.01 | +200.00% | — | — |
| Q1 2025 Feb 27, 2025 | $36.67M | $40.78M | +11.20% | -$0.03 | $0.02 | +166.67% | — | — |
| Q4 2024 Nov 12, 2024 | $37.37M | $42.27M | +13.12% | -$0.03 | -$0.03 | -9.09% | — | — |
| Q3 2024 Aug 6, 2024 | $36.62M | $36.02M | -1.63% | -$0.04 | -$0.06 | -50.00% | — | — |
| Q2 2024 May 7, 2024 | $35.89M | $34.67M | -3.40% | -$0.08 | -$0.02 | +75.00% | — | — |
| Q1 2024 Mar 12, 2024 | $30.97M | $34.23M | +10.54% | -$0.15 | -$0.07 | +53.33% | — | — |
| Q4 2023 Nov 14, 2023 | $30.94M | $31.43M | +1.60% | -$0.31 | -$0.17 | +45.16% | — | — |
| Q3 2023 Aug 14, 2023 | $31.70M | $31.76M | +0.20% | -$0.23 | -$0.35 | -52.17% | — | — |
| Q2 2023 May 11, 2023 | $29.69M | $29.61M | -0.25% | -$0.17 | -$0.27 | -58.82% | — | — |
| Q1 2023 Mar 23, 2023 | $26.90M | $30.03M | +11.63% | -$0.25 | -$0.17 | +32.00% | — | — |
| Q4 2022 Nov 8, 2022 | $26.96M | $26.56M | -1.49% | -$0.39 | -$0.38 | +2.56% | — | — |
| Q3 2022 Aug 9, 2022 | $24.55M | $27.63M | +12.54% | -$0.50 | -$0.55 | -10.00% | — | — |
| Q2 2022 May 9, 2022 | $22.61M | $23.46M | +3.76% | -$0.45 | -$0.63 | -40.00% | — | — |
| Q1 2022 Feb 28, 2022 | $25.77M | $20.66M | -19.86% | -$0.59 | -$0.54 | +8.47% | — | — |
| Q4 2021 Nov 3, 2021 | $25.51M | $23.23M | -8.94% | -$0.60 | -$0.51 | +15.00% | — | — |
| Q3 2021 Aug 9, 2021 | $22.44M | $22.44M | +0.00% | -$0.59 | -$0.62 | -5.08% | — | — |
| Q2 2021 May 10, 2021 | $25.59M | $20.02M | -21.77% | -$0.57 | -$0.58 | -1.75% | — | — |